Philippe Auzeloux

发表

Targeted Radionuclide Therapy Decreases Melanoma Lung Invasion by Modifying Epithelial-Mesenchymal Transition-Like Mechanisms☆

J. Chezal, E. Miot-Noirault, S. Besse, 2019, Translational oncology.

Efficacy of Targeted Radionuclide Therapy Using [131I]ICF01012 in 3D Pigmented BRAF- and NRAS-Mutant Melanoma Models and In Vivo NRAS-Mutant Melanoma

L. Larue, V. Petit, T. Billoux, 2021, Cancers.

Single photon emission computed tomography/positron emission tomography imaging and targeted radionuclide therapy of melanoma: new multimodal fluorinated and iodinated radiotracers.

R. Boisgard, B. Tavitian, N. Moins, 2011, Journal of medicinal chemistry.

Synthesis of two novel oxocyclam-binding technetium complexes containing an analogue of cocaine

P. Emond, E. Berthommier, P. Auzeloux, 2002 .

Stable tumor vessel normalization with pO2 increase and endothelial PTEN activation by inositol trispyrophosphate brings novel tumor treatment

G. Collet, C. Kieda, J. Lehn, 2013, Journal of Molecular Medicine.

Benzamide derivative radiotracers targeting melanin for melanoma imaging and therapy: Preclinical/clinical development and combination with other treatments.

F. Cachin, P. Auzeloux, F. Degoul, 2021, Pharmacology & therapeutics.

Macrocyclic 14-Membered Ring Diketal Diamines: Synthesis, Conformational Analysis and 99mTc Radiolabeling Evaluation

J. Madelmont, P. Auzeloux, D. Dugat, 2008 .

Preliminary studies of new proteasome inhibitors in the tumor targeting approach: synthesis and in vitro cytotoxicity.

J. Madelmont, J. Sauzieres, A. Jarrousse, 2005, Journal of medicinal chemistry.

Immune checkpoint inhibitors reverse tolerogenic mechanisms induced by melanoma targeted radionuclide therapy

M. D’Incan, S. Besse, A. Hennino, 2020, Cancer Immunology, Immunotherapy.

Early detection and longitudinal monitoring of experimental primary and disseminated melanoma using [18F]ICF01006, a highly promising melanoma PET tracer

N. Moins, J. Chezal, E. Miot-Noirault, 2012, European Journal of Nuclear Medicine and Molecular Imaging.

A potential melanoma tracer: synthesis, radiolabeling, and biodistribution in mice of a new nitridotechnetium bis(aminothiol) derivative pharmacomodulated by a N-(diethylaminoethyl)benzamide.

R. Pasqualini, J. Papon, J. Madelmont, 2000, Journal of medicinal chemistry.

Theranostic Approach for Metastatic Pigmented Melanoma Using ICF15002, a Multimodal Radiotracer for Both PET Imaging and Targeted Radionuclide Therapy1

N. Moins, F. Mishellany, J. Chezal, 2016, Neoplasia.

Synthesis, radiolabeling and preliminary in vivo evaluation of multimodal radiotracers for PET imaging and targeted radionuclide therapy of pigmented melanoma.

J. Madelmont, J. Chezal, E. Miot-Noirault, 2015, European journal of medicinal chemistry.

Small rigid platforms functionalization with quaternary ammonium: targeting extracellular matrix of chondrosarcoma.

O. Tillement, David Kryza, P. Bonazza, 2014, Nanomedicine : nanotechnology, biology, and medicine.